NIPH Clinical Trials Search

Basic Information

Recruitment status	completed
Health condition(s) or Problem(s) studied
Date of first enrollment	08/01/2020
Target sample size	118
Countries of recruitment	Japan,North America,South America,Europe,Oceania,null
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : INN of investigational material : sarilumab Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material :

Outcome(s)

Primary Outcome	efficacy
Secondary Outcome	efficacy safety safety safety safety pharmacokinetics

Key inclusion & exclusion criteria

Age minimum	>= 50age old
Age maximum	Not applicable
Gender	Both
Include criteria
Exclude criteria